Papers/PMID:41388744
Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Endocrinology, diabetes & metabolism2026The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
curcumin — no detected effect on diastolic blood pressure (setting unspecified)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×2“Meta‐analysis of 16 effect sizes demonstrated no significant alteration in DBP following supplementation of curcumin/turmeric compared to control groups (WMD: −1.20 mmHg; 95% CI: −2.84 to 0.44; p = 0.15) (Figure.”
Quoted verbatim from Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.. - Study
- meta-analysis
- Population
- adults with prediabetes or type 2 diabetes; primary endpoint
Effect -1.2 mean difference, 95% CI -2.84 to 0.44
Antihypertensive Effects of Curcumin/Turmeric Supplementation in Prediabetes and Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.2026PMID:41388744Permalink